Zydus Lifesciences Limited
ZYDUSLIFEDrug Manufacturers - Specialty & Generic
₹1,184.40+0.76%As of Oct 29vs prior close
- Market cap
- $12.4B
- P/E (TTM)
- 26.4×
- P/E (FY1)
- 29.4×
- From 52W high
- −2.52%
- EPS (LTM)
- ₹44.87
- Revenue (LTM)
- ₹285.9B
- Net margin
- 15.78%
- Dividend yield
- 0.08%
Nomior Score
65
Steady ProfileTop 17% of the scored universe
Growth58
Quality58
Value49
Momentum73
Resilience57
Growth
+16.55%revenue a year over 3 fiscal years
YE23 ₹168.8BLTM ₹285.9B
Connections
Revenue to profitYE26
19% of revenue became net profit, down 1 pt on a year.